Status:
COMPLETED
Endovascular Treatment of Aorto-iliac Disease Using in Situ Fenestration
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Peripheral Artery Disease
Abdominal Aortic Aneurysm
Eligibility:
All Genders
40-90 years
Brief Summary
In situ fenestration (ISF) could represent an alternative in the treatment of aorto-iliac disease when usual techniques are not available. The aim of this study was to present the results of ISF in ao...
Detailed Description
ISF are mainly described at the level of the aortic arch. Different means are reported to perforate the graft: the mechanical (needles, transjugular intra hepatic access needles or guidewires) or phys...
Eligibility Criteria
Inclusion
- \- Underwent in situ fenestration treatment between 2014 and 2019
Exclusion
- Patient aged \< 40 years or \> 90 years
- Under guardianship
Key Trial Info
Start Date :
November 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04062734
Start Date
November 27 2020
End Date
December 2 2020
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Vasculaire, Hôpital Ambroise Paré
Boulogne-Billancourt, France, 92100